Gary W Witherell
2004
Citations
0
Influential Citations
1
Citations
Journal
Current opinion in investigational drugs
Abstract
Glyminox (Savvy) is a vaginal gel formulation of C31G being developed by Biosyn as a potential contraceptive and for the potential prevention of transmission of sexually transmitted diseases, including HIV infection. In March 2002, glyminox was in phase II/III trials for Chlamydia treatment and as a contraceptive, and in phase II trials for herpes simplex virus shedding.